New and revised survey topics from the Center’s for Medicare and Medicaid Services (CMS) took effect in January 2022. You should expect survey teams to include these topics during review of your facility. These include surveyor expectations for COVID-19 Vaccination of Healthcare Personnel, reinforcing EMTALA obligations for maternal patients, revisions to the Emergency Management Appendix …
A safety alert was issued from Vyalire Medical regarding certain Bellavista 1000 and 1000e ventilators.
The Joint Commission (TJC) has rolled out their new business occupancy standards under LS.05.01.10 – LS.05.01.35 with 29 Elements of Performance for hospitals, critical access hospitals, behavioral health care and human services organizations effective July 1, 2021.
CMS Covid-19 Vaccine Mandate helpful guidance was put forth on January 27, 2022, issuing several documents to assist organizations and facilities in understanding the Covid-19 Vaccine Mandate Interim Final Rule.
Have you considered the benefits a mock survey can provide to help your team identify risk areas and opportunities for improvement? A mock survey is an excellent way to check your alignment with regulatory requirements and ensure your survey readiness.
Are you aware of what an immediate jeopardy citation is and how to avoid one? Understanding what it is, what the risks are in your organization and developing and implementing a plan to prevent the situation from happening in your organization is crucial.
The latest proposed revisions to USP Chapter 797- Pharmaceutical Compounding Sterile Solutions were released in September 2021 for public comment.
As Accrediting Organizations begin to conduct On-Site Surveys due to the drop in Omicron infections and the reduced acuity associated with most of those infections, CMS released QSO 22-10- All Vaccine Expectations for Surveyors Performing Federal Oversight.
CMS released QSO 22-07-All, and surveyors will begin surveying to these requirements on January 27, 2022.
NIOSH, in agreement with the manufacturer, ALG Healthcare, have agreed to rescind the NIOSH approval for specific respirators manufactured by ALG Healthcare.
